David Steinberg Investor

David Steinberg is a General Partner at Longwood Fund, a life science entrepreneur, and investor with a track record of co-founding five NASDAQ-listed companies. He specializes in venture capital, start-up founding and management, research partnering, and transactions. With a background in biology and an MBA from The University of Chicago Booth School of Business, David is a leader in developing innovative therapies for severe diseases like cancer and autoimmune conditions. His expertise in B cell therapy and targeting the tumor microenvironment has led to groundbreaking advancements in the field. (85 words)


Invests into